Immunology & Allergy, Campbelltown Hospital, University of Western Sydney, New South Wales, Australia.
Clin Exp Allergy. 2012 Feb;42(2):186-207. doi: 10.1111/j.1365-2222.2011.03891.x. Epub 2011 Nov 3.
There is comparatively little information in the public domain on the diversity in prevalence and triggers/factors associated with allergic rhinitis (AR) or allergic rhinoconjunctivitis (AR/C) in countries beyond western-Europe and North America.
To review the prevalence and the sensitizing agents/triggers and factors associated with AR/C in several countries in Africa, the Asia-Pacific region, Australia, Eastern Europe, Latin America, Middle East and Turkey.
Articles published in English in peer-reviewed journals were assessed and selected for further review, following an extensive literature search using the Medline database.
This review demonstrated that prevalence of AR and AR/C in these regions has predominantly been investigated in children; with studies indicating wide inter- and intra-regional variations ranging from 2.9% AR and 3.8% AR/C in 10-18-years-old children from one region in Turkey to 54.1% AR and 39.2% AR/C in 13-14-years-old children in one region in Nigeria. Moreover, the prevalence of AR and AR/C has increased markedly over the last decade particularly in some of the more affluent African countries, China-Taiwan and several Middle East countries, likely as a consequence of improved living standards leading to increased exposure to multiple traditional and non-traditional sensitizing agents and risk factors similar to those noted in western-Europe and North America.
Our findings suggest that the greater diversity in prevalence of AR or AR/C in populations in these regions is in contrast to the lower diversity of AR or AR/C in the 'western populations (USA and Europe), which tend to be more uniform. This review provides a comprehensive database of the important allergens and triggers which are likely to influence the prevalence of allergic rhinitis in these diverse regions, where the prevalence of allergic rhinitis is increasing and its adverse impact on the quality of life of affected individuals is increasingly recognised.
在欧美以外的国家和地区,有关变应性鼻炎(AR)或变应性鼻结膜炎(AR/C)的流行情况及其相关的变应原/触发因素或影响因素的信息相对较少。
综述非洲、亚太地区、澳大利亚、东欧、拉丁美洲、中东和土耳其等国家和地区的 AR/C 流行情况、致敏剂/触发因素和影响因素。
检索 Medline 数据库,查找并评估以英文发表的同行评议期刊上的文章,然后选择进一步审查。
本综述表明,这些地区 AR 和 AR/C 的流行情况主要在儿童中进行了研究;研究表明,区域间和区域内差异很大,从土耳其一个地区 10-18 岁儿童的 AR 为 2.9%、AR/C 为 3.8%,到尼日利亚一个地区 13-14 岁儿童的 AR 为 54.1%、AR/C 为 39.2%。此外,过去十年中,AR 和 AR/C 的患病率显著上升,尤其是在一些较富裕的非洲国家、中国台湾地区和一些中东国家,可能是由于生活水平提高,导致儿童接触多种传统和非传统致敏原和危险因素的机会增加,与欧美国家类似。
我们的研究结果表明,与“西方人群(美国和欧洲)”相比,这些地区人群的 AR 或 AR/C 患病率差异较大,而“西方人群”的 AR 或 AR/C 患病率差异较小。这一综述提供了一个综合数据库,其中包含可能影响这些多样化地区变应性鼻炎流行的重要变应原和触发因素,这些地区的变应性鼻炎患病率正在上升,其对受影响个体生活质量的不良影响也日益受到关注。